Adventitial delivery minimizes the proinflammatory effects of adenoviral vectors
Open Access
- 1 March 1999
- journal article
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 29 (3) , 543-550
- https://doi.org/10.1016/s0741-5214(99)70283-1
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Vasomotor Dysfunction Early after Exposure of Normal Rabbit Arteries to an Adenoviral VectorHuman Gene Therapy, 1997
- Downregulation of cyclin-dependent kinase 2 activity and cyclin A promoter activity in vascular smooth muscle cells by p27(KIP1), an inhibitor of neointima formation in the rat carotid artery.Journal of Clinical Investigation, 1997
- Gene therapy and vascular disease: Potential applications in vascular surgeryEuropean Journal of Vascular and Endovascular Surgery, 1997
- Established immunity precludes adenovirus-mediated gene transfer in rat carotid arteries. Potential for immunosuppression and vector engineering to overcome barriers of immunity.Journal of Clinical Investigation, 1997
- Local adenoviral–mediated expression of recombinant hirudin reduces neointima formation after arterial injuryNature Medicine, 1996
- Prevention of Arterial Thrombosis by Adenovirus-Mediated Transfer of Cyclooxygenase GeneCirculation, 1996
- Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia.Journal of Clinical Investigation, 1995
- Cytostatic Gene Therapy for Vascular Proliferative Disorders with a Constitutively Active form of the Retinoblastoma Gene ProductScience, 1995
- Gene Therapy for Cardiovascular DiseaseCirculation, 1995
- Gene Therapy for Vascular Smooth Muscle Cell Proliferation After Arterial InjuryScience, 1994